Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
6 studies found for:    gen-003
Show Display Options
Rank Status Study
1 Completed Rollover Trial for Placebo Subjects Previously Enrolled Into GEN-003-002 Study
Condition: Genital Herpes Simplex Type 2
Interventions: Biological: Matrix-M2 Adjuvant;   Biological: GEN-003 Vaccine
2 Not yet recruiting Maintenance Dose Study of GEN-003 in Subjects With Genital Herpes Infection
Conditions: Genital Herpes;   HSV-2 Infection
Interventions: Biological: GEN-003;   Biological: Matrix-M2;   Other: 0.9% normal saline
3 Active, not recruiting Long-term Follow-up of GEN-003-002 Subjects for Efficacy and Immunogenicity
Condition: Genital Herpes Simplex Type 2
Intervention: Biological: Observational
4 Active, not recruiting Evaluating New Formulation of Therapeutic HSV-2 Vaccine
Condition: Genital Herpes Simplex Type 2
Interventions: Biological: Matrix-M2;   Biological: GEN-003;   Drug: Placebo
5 Completed Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine
Condition: Genital Herpes Simplex Type 2
Interventions: Biological: Matrix-M2 Adjuvant;   Biological: GEN-003 Vaccine;   Drug: Placebo
6 Completed Safety and Immunogenicity Study of Therapeutic HSV-2 Vaccine
Condition: Genital Herpes Simplex Type 2
Interventions: Biological: GEN-003 with Matrix M-2;   Biological: GEN-003;   Biological: Placebo

Study has passed its completion date and status has not been verified in more than two years.